{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:28Z","timestamp":1760057248824,"version":"build-2065373602"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Ovarian clear cell carcinoma (OCCC) is an endometriosis-related neoplasm, in which traditional histologic grading does not show prognostic significance. Tumor budding was associated with poorer outcomes in OCCC in previous studies. We aimed to evaluate the prognostic significance of tumor budding in OCCC in an independent cohort. Seventy patients diagnosed with OCCC were retrospectively identified. Slides from primary ovarian resections were reviewed by 2 pathologists blinded to outcomes. Tumor budding was defined as single or clusters of &lt;5 tumor cells in peritumoral and\/or intratumoral nonhyalinized stroma. Most patients were diagnosed at an early stage (stage I: 69%; II: 20%; III: 10%; IV: 1%). Twenty-one patients experienced recurrences (30%) and 2 progressive disease (3%). At the last follow-up, 52 patients had no evidence of disease, 6 were alive with disease, and 12 died of disease. The median follow-up time was 66.7\u00a0mo. Tumor budding was identified in 41 cases (59%) with a kappa coefficient of 0.60. On univariate analysis, tumor budding (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.022) and stage (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0005) were associated with shorter progression-free survival (PFS), but only stage was independently associated with shorter PFS on multivariate analysis (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.003). Higher stage was the only variable associated with shorter overall survival (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.037). Tumor budding was associated with higher stage (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.039), absence of endometriosis (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.042) and adenofibroma (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.046), tumor-associated inflammation (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.002), and higher mitotic activity (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.022). There was no association between tumor budding and molecular characteristics in 32 cases with somatic tumor sequencing. Tumor budding was not independently associated with worse outcomes in this cohort of OCCC, although it was significantly associated with specific clinicopathologic features, including higher stage. Stage was the only independent variable predictive of poorer survival, which appears to drive the prognostic significance of tumor budding.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001099","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:01:04Z","timestamp":1737975664000},"page":"519-525","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Validation of Tumor Budding as a Prognostic Factor in Ovarian Clear Cell Carcinoma Using an Independent Cohort"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9603-9783","authenticated-orcid":false,"given":"Lawrence H.","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Irshaid","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula A.","family":"Matulonis","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kolin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Women\u2019s and Perinatal Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.path.2019.01.009","article-title":"Pathology of endometrioid and clear cell carcinoma of the ovary","volume":"12","author":"Fadare","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","article-title":"Clear cell carcinoma of the ovary: epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"162","author":"Gadducci","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ijgc-2020-001656","article-title":"Clear cell carcinoma of the ovary: a clinical and molecular perspective","volume":"31","author":"Iida","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0b013e3181ff400e","article-title":"Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases","volume":"35","author":"Delair","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"100123","DOI":"10.1016\/j.modpat.2023.100123","article-title":"Molecular landscape of mullerian clear cell carcinomas identifies the cancer genome atlas-like prognostic subgroups","volume":"36","author":"Irshaid","year":"2023","journal-title":"Mod Pathol"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/PAS.0000000000001328","article-title":"p53, mismatch repair protein, and POLE abnormalities in ovarian clear cell carcinoma: an outcome-based clinicopathologic analysis","volume":"43","author":"Parra-Herran","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/his.12514","article-title":"Clear cell carcinoma of the ovary: evaluation of prognostic parameters based on a clinicopathological analysis of 100 cases","volume":"66","author":"Bennett","year":"2015","journal-title":"Histopathology"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/his.14459","article-title":"Intratumoral budding is associated with poor clinical outcome in early-stage clear cell carcinoma of ovary","volume":"79","author":"Lin","year":"2021","journal-title":"Histopathology"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","article-title":"Tumour budding in solid cancers","volume":"18","author":"Lugli","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/bjc.2014.228","article-title":"Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer","volume":"110","author":"Tanaka","year":"2014","journal-title":"Br J Cancer"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/his.15154","article-title":"Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis","volume":"84","author":"Park","year":"2024","journal-title":"Histopathology"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2018.06.012","article-title":"Tumor budding is associated with poor prognosis of oral squamous cell carcinoma and histologically represents an epithelial-mesenchymal transition process","volume":"80","author":"Hong","year":"2018","journal-title":"Hum Pathol"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/PGP.0000000000000936","article-title":"Ovarian clear cell carcinoma and markers of epithelial-mesenchymal transition (EMT): immunohistochemical characterization of tumor budding","volume":"42","author":"Lin","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2014.12.006","article-title":"Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion","volume":"136","author":"Matsuo","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAS.0000000000001181","article-title":"Tumor budding and prognosis in gastric adenocarcinoma","volume":"43","author":"Kemi","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R19-20251009","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4251\/wjgo.v11.i10.898","article-title":"Prognostic and pathological impact of tumor budding in gastric cancer: a systematic review and meta-analysis","volume":"11","author":"Guo","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"R20-20251009","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/his.12781","article-title":"Prognostic value of tumour budding in oesophageal cancer: a meta-analysis","volume":"68","author":"Almangush","year":"2016","journal-title":"Histopathology"},{"key":"R21-20251009","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1245\/s10434-008-9901-6","article-title":"Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor","volume":"15","author":"Koike","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R22-20251009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.prp.2013.01.009","article-title":"The prognostic value of tumor budding in invasive breast cancer","volume":"209","author":"Liang","year":"2013","journal-title":"Pathol Res Pract"},{"key":"R23-20251009","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjc.2015.287","article-title":"The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer","volume":"113","author":"Gujam","year":"2015","journal-title":"Br J Cancer"},{"key":"R24-20251009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/bjc.2017.425","article-title":"Tumour budding in oral squamous cell carcinoma: a meta-analysis","volume":"118","author":"Almangush","year":"2018","journal-title":"Br J Cancer"},{"key":"R25-20251009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/jcm5050051","article-title":"Tumor budding: the name is EMT. Partial EMT","volume":"5","author":"Grigore","year":"2016","journal-title":"J Clin Med"},{"key":"R26-20251009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2019.11.017","article-title":"Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes","volume":"50","author":"Tan","year":"2019","journal-title":"EBioMedicine"},{"key":"R27-20251009","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2008.05.025","article-title":"Prognostic implication of endometriosis in clear cell carcinoma of the ovary","volume":"110","author":"Orezzoli","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R28-20251009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/igc.0000000000001136","article-title":"Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma","volume":"28","author":"Park","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R29-20251009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-018-0425-9","article-title":"Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute","volume":"11","author":"Zhao","year":"2018","journal-title":"J Ovarian Res"},{"key":"R30-20251009","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1245\/s10434-014-4319-9","article-title":"Effect of endometriosis on the prognosis of ovarian clear cell carcinoma: a two-center cohort study and meta-analysis","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R31-20251009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijgo.12861","article-title":"The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma","volume":"146","author":"Ju","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R32-20251009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00404-018-4651-6","article-title":"Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?","volume":"297","author":"Sahin","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R33-20251009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12672-023-00649-8","article-title":"Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort","volume":"14","author":"Sun","year":"2023","journal-title":"Discov Oncol"},{"key":"R34-20251009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-8258(89)90043-7","article-title":"Clear cell carcinoma of the ovary: a study of 59 cases","volume":"35","author":"Crozier","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R35-20251009","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/gyno.1993.1221","article-title":"Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma","volume":"50","author":"Kennedy","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R36-20251009","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/1097-0142(19810315)47:6<1344::AID-CNCR2820470618>3.0.CO;2-3","article-title":"Clear cell carcinoma of the ovary: a clinicopathologic study with review of the literature","volume":"47","author":"Shevchuk","year":"1981","journal-title":"Cancer"},{"key":"R37-20251009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13000-021-01071-w","article-title":"Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma","volume":"16","author":"Ge","year":"2021","journal-title":"Diagn Pathol"},{"key":"R38-20251009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PGP.0000000000000682","article-title":"Diffuse intratumoral stromal inflammation in ovarian clear cell carcinoma is associated with loss of mismatch repair protein and high PD-L1 expression","volume":"40","author":"Lin","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20251009","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jso.25965","article-title":"Clinicopathological and survival characteristic of mismatch repair status in ovarian clear cell carcinoma","volume":"122","author":"Zhu","year":"2020","journal-title":"J Surg Oncol"},{"key":"R40-20251009","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2021.05.010","article-title":"Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary","volume":"162","author":"Sue-A-Quan","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R41-20251009","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41416-022-01705-w","article-title":"Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma","volume":"126","author":"Ye","year":"2022","journal-title":"Br J Cancer"},{"key":"R42-20251009","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/ijc.34428","article-title":"Immune-hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma","volume":"152","author":"Huang","year":"2023","journal-title":"Int J Cancer"},{"key":"R43-20251009","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ajcp\/aqad073","article-title":"Clinical outcome and morphology-based analysis of p53 aberrant and mismatch repair protein-deficient ovarian clear cell carcinoma and their association with p16, HER2, and PD-L1 expression","volume":"160","author":"Wilkins","year":"2023","journal-title":"Am J Clin Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:00:47Z","timestamp":1760025647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001099","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"type":"print","value":"0277-1691"},{"type":"electronic","value":"1538-7151"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}